Acquisition Announced Sponsor buyer

Veloxis Pharmaceuticals acquisition of AiCuris Anti-infective Cures AG

€780m consideration

Announced 26 Feb 2026

Advisers

Target
AiCuris Anti-infective Cures AG
Acquirer
Veloxis Pharmaceuticals
Sponsor
Asahi Kasei Group
Target based in
Germany
Buyer based in
United States
Sector
Pharma
Tags
Pharma, Drug Development

In the league tables

Similar deals

All pharma deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.